Product Code: GVR-4-68040-585-2
Wound Sealants Market Size & Trends:
The global wound sealants market size was valued at USD 552.13 million in 2024 and is expected to expand at a CAGR of 5.63% from 2025 to 2030. The market's growth is attributed to the rising global volume of surgical procedures, fueled by an aging population and the increasing prevalence of chronic conditions such as diabetes and cardiovascular diseases.
The growing demand for minimally invasive surgeries, which require efficient and reliable wound closure methods, further boosts the adoption of sealants. In addition, advancements in biomaterials and synthetic formulations are enhancing wound sealants' effectiveness, safety, and usability, making them a preferred choice in traditional and modern surgical practices.
The rising prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, is anticipated to propel the market growth in the coming years. According to the article published by MDPI, in March 2025, diabetic foot is one of the most serious and challenging complications of diabetes, closely linked to high rates of lower limb amputation, as well as increased illness and mortality. Each year, around 18.6 million people globally are affected by diabetic foot ulcers, which are the leading cause of approximately 80% of diabetes-related lower limb amputations. It is estimated that up to 25% of individuals with diabetes are at risk of developing diabetic foot, and between 19% and 34% may experience foot ulcers at some point in their lifetime. Moreover, according to a study published by the American Medical Association in November 2023, around 33.33% of individuals with diabetes develop a foot ulcer during their lifetime. Diabetic foot ulcers impact about 1.6 million individuals in the U.S. each year. These factors are expected to drive the demand for wound sealants over the forecast period.
The growing number of surgical procedures, including cosmetic, orthopedic, and gynecologic, is anticipated to boost the market growth in the coming years. Wound sealants are widely used in various surgical procedures.
Ongoing innovation in sealant technology, with the development of improved biomaterials, delivery methods, and functionalities, is expanding its applications and driving market growth. For instance, in November 2023, Ethicon, a Johnson & Johnson MedTech company, announced the approval of ETHIZIA. This adjunctive hemostat solution has been clinically proven to achieve sustained hemostasis in challenging bleeding scenarios. Utilizing unique synthetic polymer technology, the ETHIZIA Hemostatic Sealing Patch is the first and only hemostatic matrix designed to provide equally effective hemostatic action on both sides. Furthermore, the trend toward minimally invasive and robotic surgeries has strengthened the need for sealants, as these procedures require precision and controlled closure without excessive tissue manipulation.
Moreover, increasing awareness among healthcare professionals and patients about the advantages of advanced wound care products, including wound sealants, is driving their adoption and supporting market growth. This awareness is being fueled by educational campaigns, clinical evidence showcasing their effectiveness, and a strong focus on achieving better patient outcomes.
Global Wound Sealants Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global wound sealants market report on the basis of sealants, wound type, end use, distribution channel, and region:
- Sealants Outlook (Revenue, USD Million, 2018 - 2030)
- Non-Synthetic
- Collagen Based
- Synthetic
- Wound Type Outlook (Revenue, USD Million, 2018 - 2030)
- Acute Wounds
- Surgical/ Procedure
- Obstetrics / Gynecology
- Colorectal
- Cardiovascular
- Bariatric and Upper GI
- Plastic and Reconstructive Surgery
- Urology
- Hepato-pancreato-biliary (HPB)
- Dermatology
- Others (ENT, Ortho trauma, Neuro, etc.)
- Lacerations & Minor Cuts
- Burns
- Chronic Wounds
- Diabetic Foot Ulcers
- Pressure Ulcers
- Venous Leg Ulcers
- Other Chronic Wounds
- End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Acute Care Hospital
- Ambulatory Surgery Center (ASC)
- Hospital Outpatient Wound Care Clinic
- Home Healthcare
- Skilled Nursing Facility (SNF)
- Physician Office
- Burn Center
- Inpatient Rehabilitation Facility (IRF)
- Long-term Acute Care Hospital (LTACH)
- Long-term Care (residential living setting)
- Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
- Institutional Sales
- Retail Sales
- Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- Kuwait
- UAE
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.4. Purchased database.
- 1.5. GVR's internal database
- 1.6. Secondary sources
- 1.7. Third Party Perspective
- 1.8. Primary research
- 1.9. Details of primary research
- 1.10. Information or Data Analysis
- 1.11. Data analysis models
- 1.12. Market Formulation & Validation
- 1.13. Model Details
- 1.14. Commodity flow analysis (Model 1)
- 1.15. Approach 1: Commodity flow approach
- 1.16. Volume price analysis (Model 2)
- 1.17. Approach 2: Volume price analysis
- 1.18. List of Secondary Sources
- 1.19. List of Primary Sources
- 1.20. List of Abbreviations
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Wound Sealants Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Rising prevalence of chronic diseases
- 3.2.1.2. Rising surgical volume worldwide
- 3.2.1.3. Growing preference for minimally invasive surgeries
- 3.2.2. Market Restraint Analysis
- 3.2.3. Market Opportunities Analysis
- 3.2.4. Market Challenges Analysis
- 3.3. Wound Sealants Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political & Legal Landscape
- 3.3.2.2. Economic and Social Landscape
- 3.3.2.3. Technological landscape
- 3.3.3. COVID-19 Impact Analysis
- 3.3.3.1. Disrupted Breast Pump
- 3.3.3.2. Obstacles in Breast Pump
Chapter 4. Wound Sealants Market: Sealants Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Wound Sealants Market: Sealants Movement Analysis & Market Share, 2024 & 2030
- 4.3. Non-Synthetic
- 4.3.1. Non-Synthetic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4. Collagen based
- 4.4.1. Collagen Based Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5. Synthetic
- 4.5.1. Synthetic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Wound Sealants Market: Wound Type Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Wound Sealants Market: Wound Type Movement Analysis & Market Share, 2024 & 2030
- 5.3. Acute Wounds
- 5.3.1. Acute Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.2. Surgical/ Procedure
- 5.3.2.1. Surgical/ Procedure Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.2.2. Obstetrics / Gynecology
- 5.3.2.2.1. Obstetrics / Gynecology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.2.3. Colorectal
- 5.3.2.3.1. Colorectal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.2.4. Cardiovascular
- 5.3.2.4.1. Cardiovascular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.2.5. Bariatric and Upper GI
- 5.3.2.5.1. Bariatric and Upper GI Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.2.6. Plastic and Reconstructive Surgery
- 5.3.2.6.1. Plastic and Reconstructive Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.2.7. Urology
- 5.3.2.7.1. Urology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.2.8. Hepatopancreatobiliary (HPB)
- 5.3.2.8.1. Hepatopancreatobiliary (HPB) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.2.9. Dermatology
- 5.3.2.9.1. Dermatology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.2.10. Others (ENT, Ortho trauma, Neuro, etc.)
- 5.3.2.10.1. Others (ENT, Ortho trauma, Neuro, etc.) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.3. Lacerations & Minor Cuts
- 5.3.3.1. Lacerations & Minor Cuts Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.4. Burns
- 5.3.4.1. Burns Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4. Chronic Wounds
- 5.4.1. Chronic Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.2. Diabetic Foot Ulcers
- 5.4.2.1. Diabetic Foot Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.3. Pressure Ulcers
- 5.4.3.1. Pressure Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.4. Venous Leg Ulcers
- 5.4.4.1. Venous Leg Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4.5. Other Chronic Wounds
- 5.4.5.1. Other Chronic Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Wound Sealants Market: End Use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Wound Sealants Market: End Use Movement Analysis & Market Share, 2024 & 2030
- 6.3. Acute Care Hospital
- 6.3.1. Acute Care Hospital Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4. Ambulatory Surgery Center (ASC)
- 6.4.1. Ambulatory Surgery Center (ASC) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5. Hospital Outpatient Wound Care Clinic
- 6.5.1. Hospital Outpatient Wound Care Clinic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6. Home Healthcare
- 6.6.1. Home Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.7. Skilled Nursing Facility (SNF)
- 6.7.1. Skilled Nursing Facility (SNF) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.8. Physician Office
- 6.8.1. Physician Office Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.9. Burn Center
- 6.9.1. Burn Center Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.10. Inpatient Rehabilitation Facility (IRF)
- 6.10.1. Inpatient Rehabilitation Facility (IRF) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.11. Long-term Acute Care Hospital (LTACH)
- 6.11.1. Long-term Acute Care Hospital (LTACH) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.12. Long-term Care (residential living setting)
- 6.12.1. Long-term Care (residential living setting) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Wound Sealants Market: Distribution Channel Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Wound Sealants Market: Distribution Channel Movement Analysis & Market Share, 2024 & 2030
- 7.3. Institutional Sales
- 7.3.1. Institutional Sales Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4. Retail Sales
- 7.4.1. Retail Sales Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Wound Sealants Market: Regional Estimates & Trend Analysis
- 8.1. Regional Outlook
- 8.2. Wound Sealants Market: Regional Movement Analysis & Market Share, 2024 & 2030
- 8.3. North America
- 8.3.1. North America Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.2. U.S.
- 8.3.2.1. Key Country Dynamics
- 8.3.2.2. Competitive Scenario
- 8.3.2.3. Regulatory Scenario
- 8.3.2.4. Reimbursement Scenario
- 8.3.2.5. U.S. Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.3. Canada
- 8.3.3.1. Key Country Dynamics
- 8.3.3.2. Competitive Scenario
- 8.3.3.3. Regulatory Scenario
- 8.3.3.4. Reimbursement Scenario
- 8.3.3.5. Canada Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.4. Mexico
- 8.3.4.1. Key Country Dynamics
- 8.3.4.2. Competitive Scenario
- 8.3.4.3. Regulatory Scenario
- 8.3.4.4. Reimbursement Scenario
- 8.3.4.5. Mexico Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4. Europe
- 8.4.1. Europe Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.2. UK
- 8.4.2.1. Key Country Dynamics
- 8.4.2.2. Competitive Scenario
- 8.4.2.3. Regulatory Scenario
- 8.4.2.4. Reimbursement Scenario
- 8.4.2.5. UK Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.3. Germany
- 8.4.3.1. Key Country Dynamics
- 8.4.3.2. Competitive Scenario
- 8.4.3.3. Regulatory Scenario
- 8.4.3.4. Reimbursement Scenario
- 8.4.3.5. Germany Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.4. France
- 8.4.4.1. Key Country Dynamics
- 8.4.4.2. Competitive Scenario
- 8.4.4.3. Regulatory Scenario
- 8.4.4.4. Reimbursement Scenario
- 8.4.4.5. France Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.5. Italy
- 8.4.5.1. Key Country Dynamics
- 8.4.5.2. Competitive Scenario
- 8.4.5.3. Regulatory Scenario
- 8.4.5.4. Reimbursement Scenario
- 8.4.5.5. Italy Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.6. Spain
- 8.4.6.1. Key Country Dynamics
- 8.4.6.2. Competitive Scenario
- 8.4.6.3. Regulatory Scenario
- 8.4.6.4. Reimbursement Scenario
- 8.4.6.5. Spain Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.7. Denmark
- 8.4.7.1. Key Country Dynamics
- 8.4.7.2. Competitive Scenario
- 8.4.7.3. Regulatory Scenario
- 8.4.7.4. Reimbursement Scenario
- 8.4.7.5. Denmark Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.8. Sweden
- 8.4.8.1. Key Country Dynamics
- 8.4.8.2. Competitive Scenario
- 8.4.8.3. Regulatory Scenario
- 8.4.8.4. Reimbursement Scenario
- 8.4.8.5. Sweden Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.9. Norway
- 8.4.9.1. Key Country Dynamics
- 8.4.9.2. Competitive Scenario
- 8.4.9.3. Regulatory Scenario
- 8.4.9.4. Reimbursement Scenario
- 8.4.9.5. Norway Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5. Asia Pacific
- 8.5.1. Asia Pacific Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.2. Japan
- 8.5.2.1. Key Country Dynamics
- 8.5.2.2. Competitive Scenario
- 8.5.2.3. Regulatory Scenario
- 8.5.2.4. Reimbursement Scenario
- 8.5.2.5. Japan Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.3. China
- 8.5.3.1. Key Country Dynamics
- 8.5.3.2. Competitive Scenario
- 8.5.3.3. Regulatory Scenario
- 8.5.3.4. Reimbursement Scenario
- 8.5.3.5. China Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.4. India
- 8.5.4.1. Key Country Dynamics
- 8.5.4.2. Competitive Scenario
- 8.5.4.3. Regulatory Scenario
- 8.5.4.4. Reimbursement Scenario
- 8.5.4.5. India Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.5. South Korea
- 8.5.5.1. Key Country Dynamics
- 8.5.5.2. Competitive Scenario
- 8.5.5.3. Regulatory Scenario
- 8.5.5.4. Reimbursement Scenario
- 8.5.5.5. South Korea Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.6. Australia
- 8.5.6.1. Key Country Dynamics
- 8.5.6.2. Competitive Scenario
- 8.5.6.3. Regulatory Scenario
- 8.5.6.4. Reimbursement Scenario
- 8.5.6.5. Australia Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.7. Thailand
- 8.5.7.1. Key Country Dynamics
- 8.5.7.2. Competitive Scenario
- 8.5.7.3. Regulatory Scenario
- 8.5.7.4. Reimbursement Scenario
- 8.5.7.5. Thailand Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6. Latin America
- 8.6.1. Latin America Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.2. Brazil
- 8.6.2.1. Key Country Dynamics
- 8.6.2.2. Competitive Scenario
- 8.6.2.3. Regulatory Scenario
- 8.6.2.4. Reimbursement Scenario
- 8.6.2.5. Brazil Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.3. Argentina
- 8.6.3.1. Key Country Dynamics
- 8.6.3.2. Competitive Scenario
- 8.6.3.3. Regulatory Scenario
- 8.6.3.4. Reimbursement Scenario
- 8.6.3.5. Argentina Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7. Middle East & Africa
- 8.7.1. Middle East & Africa Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.2. South Africa
- 8.7.2.1. Key Country Dynamics
- 8.7.2.2. Competitive Scenario
- 8.7.2.3. Regulatory Scenario
- 8.7.2.4. Reimbursement Scenario
- 8.7.2.5. South Africa Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.3. Saudi Arabia
- 8.7.3.1. Key Country Dynamics
- 8.7.3.2. Competitive Scenario
- 8.7.3.3. Regulatory Scenario
- 8.7.3.4. Reimbursement Scenario
- 8.7.3.5. Saudi Arabia Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.4. UAE
- 8.7.4.1. Key Country Dynamics
- 8.7.4.2. Competitive Scenario
- 8.7.4.3. Regulatory Scenario
- 8.7.4.4. Reimbursement Scenario
- 8.7.4.5. UAE Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.5. Kuwait
- 8.7.5.1. Key Country Dynamics
- 8.7.5.2. Competitive Scenario
- 8.7.5.3. Regulatory Scenario
- 8.7.5.4. Reimbursement Scenario
- 8.7.5.5. Kuwait Wound Sealants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Market Participant Categorization
- 9.2. Key Company Profiles
- 9.2.1. Terumo Corporation
- 9.2.1.1. Company Overview
- 9.2.1.2. Financial Performance
- 9.2.1.3. Product Benchmarking
- 9.2.1.4. Strategic Initiatives
- 9.2.2. Baxter
- 9.2.2.1. Company Overview
- 9.2.2.2. Financial Performance
- 9.2.2.3. Product Benchmarking
- 9.2.2.4. Strategic Initiatives
- 9.2.3. Advanced Medical Solutions Group plc
- 9.2.3.1. Company Overview
- 9.2.3.2. Financial Performance
- 9.2.3.3. Product Benchmarking
- 9.2.3.4. Strategic Initiatives
- 9.2.4. Johnson & Johnson (Ethicon)
- 9.2.4.1. Company Overview
- 9.2.4.2. Financial Performance
- 9.2.4.3. Product Benchmarking
- 9.2.4.4. Strategic Initiatives
- 9.2.5. BD
- 9.2.5.1. Company Overview
- 9.2.5.2. Financial Performance
- 9.2.5.3. Product Benchmarking
- 9.2.5.4. Strategic Initiatives
- 9.2.6. Integra LifeSciences Corporation
- 9.2.6.1. Company Overview
- 9.2.6.2. Financial Performance
- 9.2.6.3. Product Benchmarking
- 9.2.6.4. Strategic Initiatives
- 9.2.7. Cohera Medical, Inc.
- 9.2.7.1. Company Overview
- 9.2.7.2. Financial Performance
- 9.2.7.3. Product Benchmarking
- 9.2.7.4. Strategic Initiatives
- 9.2.8. LifeBond Ltd.
- 9.2.8.1. Company Overview
- 9.2.8.2. Financial Performance
- 9.2.8.3. Product Benchmarking
- 9.2.8.4. Strategic Initiatives
- 9.3. Heat Map Analysis/ Company Market Position Analysis
- 9.4. Estimated Company Market Share Analysis, 2024
- 9.5. List of Other Key Market Players